Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Vivos (RDGL) Research & Development (2017 - 2025)

Vivos (RDGL) has disclosed Research & Development for 9 consecutive years, with $57166.0 as the latest value for Q4 2025.

  • Quarterly Research & Development fell 43.38% to $57166.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $352232.0 through Dec 2025, up 8.5% year-over-year, with the annual reading at $352232.0 for FY2025, 8.5% up from the prior year.
  • Research & Development hit $57166.0 in Q4 2025 for Vivos, down from $67820.0 in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $432112.0 in Q4 2023 to a low of $31736.0 in Q4 2022.
  • Historically, Research & Development has averaged $102060.5 across 5 years, with a median of $72134.5 in 2021.
  • Biggest five-year swings in Research & Development: skyrocketed 6874.71% in 2021 and later crashed 76.63% in 2024.
  • Year by year, Research & Development stood at $65694.0 in 2021, then crashed by 51.69% to $31736.0 in 2022, then soared by 1261.58% to $432112.0 in 2023, then plummeted by 76.63% to $100969.0 in 2024, then tumbled by 43.38% to $57166.0 in 2025.
  • Business Quant data shows Research & Development for RDGL at $57166.0 in Q4 2025, $67820.0 in Q3 2025, and $107965.0 in Q2 2025.